Cognios Beta Neutral Large Cap Fund LP Sells 142 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cognios Beta Neutral Large Cap Fund LP lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,349 shares of the healthcare conglomerate’s stock after selling 142 shares during the quarter. UnitedHealth Group makes up approximately 0.9% of Cognios Beta Neutral Large Cap Fund LP’s holdings, making the stock its 23rd biggest holding. Cognios Beta Neutral Large Cap Fund LP’s holdings in UnitedHealth Group were worth $710,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. Robbins Farley bought a new position in UnitedHealth Group during the 3rd quarter worth approximately $25,000. Richelieu Gestion SA bought a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. CGC Financial Services LLC boosted its stake in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC boosted its stake in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its stake in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research note on Friday, April 19th. Oppenheimer reaffirmed an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Truist Financial reiterated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, TD Cowen lowered their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $570.05.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

UNH stock traded up $1.12 during midday trading on Wednesday, reaching $487.30. 3,722,296 shares of the company were exchanged, compared to its average volume of 4,532,990. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The business has a 50-day moving average price of $487.49 and a two-hundred day moving average price of $514.76. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The firm has a market capitalization of $449.26 billion, a price-to-earnings ratio of 29.48, a price-to-earnings-growth ratio of 1.42 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.26 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s payout ratio is presently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.